Becker's Healthcare September 3, 2024
Claire Wallace

A new study has found that patients taking weight loss medications including Ozempic and Wegovy are less likely to die from COVID-19, according to a Sept. 2 report from CNBC.

While individuals taking semaglutide can still contract COVID-19, they had a 33% lower chance of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Patient / Consumer, Pharma / Biotech, Public Health / COVID
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Share This Article